What Researchers Did
Researchers conducted a bibliographic review of Medline and Cochrane databases to assess the potential use of hyperbaric oxygen therapy (HBOT) in children after COVID-19.
What They Found
The review identified 13 publications describing the efficacy of hyperbaric oxygen therapy (HBOT) for various pediatric conditions, such as carbon monoxide poisoning and burns. However, no scientific journal evidence was found regarding the effectiveness of HBOT specifically for children with a history of COVID-19 infection or its complications.
What This Means for Canadian Patients
Canadian children recovering from COVID-19 currently lack evidence-based treatment options involving hyperbaric oxygen therapy. This means that HBOT is not a recommended or proven treatment for post-COVID complications in pediatric patients at this time.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A key limitation is the absence of existing research data specifically on hyperbaric oxygen therapy for children after COVID-19, which prevented a conclusive review.